18 May 2013
Keywords: qiagen, buy, artus, gmbh, 39m, deal, netherlands-based
Article | 06 June 2005
Netherlands-based Qiagen NV, a leading provider of innovative enabling technologies and products for the separation, purification and handling
of nucleic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 June 2005
17 May 2013
© 2013 thepharmaletter.com